Display Settings:

Format

Send to:

Choose Destination
J Visc Surg. 2011 Sep;148(4):e311-4. doi: 10.1016/j.jviscsurg.2011.06.005. Epub 2011 Aug 26.

Mesenteric myofibroblastic tumor: NSAID therapy after incomplete resection.

Author information

  • 1Service de chirurgie, hôpital militaire de Ouakam, Dakar, Senegal. dballa33@yahoo.fr

Abstract

Myofibroblastic tumors are inflammatory tumors that arise in viscera and soft tissue; their etiopathology is poorly understood. They are capable of infiltration of adjacent organs, local recurrence after surgical resection, and even of distant metastasis. These characteristics result in persistent debate as to the nature of these lesions - whether they are inflammatory or neoplastic, benign or malignant lesions? Diagnosis is almost always made based on histopathological findings. Traditional management is complete surgical excision, but this may be difficult or impossible when the lesion develops in proximity to vital structures. We report the case of a 59-year-old man who was treated in our institution for mesenteric myofibroblastic tumor. Complete resection was not possible due to local infiltration of the mesentery. Recurrence was noted 3 months after surgery; treatment with steroidal and then non-steroidal anti-inflammatory medications (NSAIDs) resulted in clinical and radiologic regression of the tumor.

Copyright © 2011 Elsevier Masson SAS. All rights reserved.

PMID:
21872549
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk